Total Payments
$852.67
2021 Payments
$28.03
Companies
18
Transactions
35
Medicare Patients
1,236
Medicare Billing
$131,537
Payment Breakdown by Category
Food & Beverage$620.23 (72.7%)
Education$219.22 (25.7%)
Other$13.22 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $620.23 | 30 | 72.7% |
| Education | $219.22 | 4 | 25.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13.22 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $256.05 | 6 | $0 (2020) |
| AbbVie, Inc. | $134.44 | 2 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $74.47 | 5 | $0 (2019) |
| Janssen Biotech, Inc. | $72.44 | 5 | $0 (2019) |
| EMD Serono, Inc. | $46.78 | 2 | $0 (2017) |
| Maquet Cardiovascular U.S. Sales, L.L.C. | $41.55 | 1 | $0 (2020) |
| ViiV Healthcare Company | $40.64 | 3 | $0 (2020) |
| Echosens North America, Inc. | $31.42 | 1 | $0 (2017) |
| Allergan Inc. | $22.73 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $18.12 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $28.03 | 2 | Insmed, Inc. ($16.24) |
| 2020 | $82.38 | 4 | Maquet Cardiovascular U.S. Sales, L.L.C. ($41.55) |
| 2019 | $31.46 | 2 | Janssen Biotech, Inc. ($15.74) |
| 2018 | $109.16 | 7 | Janssen Biotech, Inc. ($26.00) |
| 2017 | $601.64 | 20 | Astellas Pharma US Inc ($240.92) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/27/2021 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 03/02/2021 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 08/12/2020 | Maquet Cardiovascular U.S. Sales, L.L.C. | SERVO (Device) | Food and Beverage | In-kind items and services | $41.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/10/2020 | Astellas Pharma US Inc | CRESEMBA (Drug), AMBISOME, MYCAMINE | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: HOSPITAL AND TRANSPLANT | ||||||
| 03/03/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: HIV | ||||||
| 02/05/2020 | Napo Pharmaceuticals Inc | Mytesi (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $13.22 | General |
| Category: Infectious Disease | ||||||
| 10/10/2019 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), PIFELTRO, DIFICID | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/25/2019 | Janssen Biotech, Inc. | Symtuza (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 11/14/2018 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $10.22 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/26/2018 | PFIZER INC. | ELELYSO (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: METABOLIC DISEASE | ||||||
| 09/25/2018 | ViiV Healthcare Company | TRIUMEQ (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: HIV | ||||||
| 08/28/2018 | Janssen Biotech, Inc. | Symtuza (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 05/10/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/08/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.07 | General |
| 03/01/2018 | Janssen Biotech, Inc. | PREZCOBIX (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 12/21/2017 | EMD Serono, Inc. | SEROSTIM (Biological) | Food and Beverage | Cash or cash equivalent | $25.09 | General |
| Category: Endocrinology | ||||||
| 10/26/2017 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.00 | General |
| 10/26/2017 | Astellas Pharma US Inc | — | Education | In-kind items and services | $59.99 | General |
| 10/05/2017 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), ASMANEX, DULERA | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: VACCINE | ||||||
| 09/21/2017 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Virology | ||||||
| 08/30/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/24/2017 | Astellas Pharma US Inc | Cresemba (Drug), Mycamine, Ambisome | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Infectious Diseases | ||||||
| 08/23/2017 | AbbVie, Inc. | Viekira (Drug) | Food and Beverage | In-kind items and services | $115.00 | General |
| Category: Virology | ||||||
| 08/18/2017 | ViiV Healthcare Company | TRIUMEQ (Drug) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: HIV | ||||||
| 07/28/2017 | Astellas Pharma US Inc | Cresemba (Drug), Lexiscan, Mycamine | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Infectious Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 102 | 163 | $75,660 | $19,394 |
| 2022 | 3 | 95 | 190 | $51,853 | $16,038 |
| 2021 | 6 | 681 | 897 | $167,437 | $48,272 |
| 2020 | 7 | 358 | 672 | $149,104 | $47,832 |
Total Patients
1,236
Total Services
1,922
Medicare Billing
$131,537
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 61 | 116 | $47,560 | $13,348 | 28.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 27 | 28 | $22,400 | $4,585 | 20.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 19 | $5,700 | $1,461 | 25.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 51 | 132 | $38,183 | $12,143 | 31.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 21 | 30 | $7,356 | $2,146 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 23 | 28 | $6,314 | $1,749 | 27.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 475 | 479 | $77,119 | $18,371 | 23.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 86 | 218 | $50,794 | $17,545 | 34.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 43 | 90 | $14,670 | $5,081 | 34.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 41 | 71 | $16,756 | $4,768 | 28.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 16 | $7,232 | $2,323 | 32.1% |
| 91200 | Measuring the stiffness in the liver via elastography | Facility | 2021 | 20 | 23 | $866.00 | $184.38 | 21.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 92 | 220 | $51,260 | $18,148 | 35.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 75 | 226 | $36,838 | $12,976 | 35.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 12 | 28 | $17,192 | $4,929 | 28.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 94 | 94 | $15,134 | $3,904 | 25.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 50 | 69 | $16,284 | $3,640 | 22.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 19 | 19 | $8,588 | $2,867 | 33.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 16 | 16 | $3,808 | $1,369 | 36.0% |
About Dr. Nicholas Sells, M.D
Dr. Nicholas Sells, M.D is a Internal Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2009. The National Provider Identifier (NPI) number assigned to this provider is 1225266349.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicholas Sells, M.D has received a total of $852.67 in payments from pharmaceutical and medical device companies, with $28.03 received in 2021. These payments were reported across 35 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($620.23).
As a Medicare-enrolled provider, Sells has provided services to 1,236 Medicare beneficiaries, totaling 1,922 services with total Medicare billing of $131,537. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Infectious Disease, Infectious Disease
- Location New York, NY
- Active Since 06/26/2009
- Last Updated 05/27/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1225266349
Products in Payments
- Viekira (Drug) $115.00
- SEROSTIM (Biological) $46.78
- PREZCOBIX (Drug) $42.88
- SERVO (Device) $41.55
- ZERBAXA (Drug) $40.85
- Cresemba (Drug) $37.94
- Fibroscan (Device) $31.42
- Symtuza (Drug) $29.56
- TRIUMEQ (Drug) $28.16
- AVYCAZ (Drug) $22.73
- Mavyret (Drug) $19.44
- INVOKANA (Drug) $18.12
- PNEUMOVAX 23 (Biological) $17.90
- Arikayce (Drug) $16.24
- ELELYSO (Drug) $16.15
- SUSTIVA (Drug) $15.95
- ISENTRESS (Drug) $15.72
- CRESEMBA (Drug) $15.13
- DARAPRIM (Drug) $13.39
- Mytesi (Drug) $13.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in New York
Dr. Stephen Saletan, M.d, M.D
Internal Medicine — Payments: $2.7M
Internal Medicine $2.7M
Michael Schuster, Md, MD
Internal Medicine — Payments: $2.1M
Internal Medicine $2.1M
Dr. Ziad Ali, Md Dphil, MD DPHIL
Internal Medicine — Payments: $1.7M
Internal Medicine $1.7M
Dr. James Underberg, Md, MD
Internal Medicine — Payments: $1.5M
Internal Medicine $1.5M
Dr. Ricky Hsu, Md, MD
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Gail Roboz, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M